Gefitinib With or Without Pemetrexed/Cisplatin in Brain Metastases From Non-small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This is a multi-center phase II randomized controlled study to assess the efficacy of
Gefitinib alone and Gefitinib combinating with Pemetrexed/cisplatin on patients with brain
metastasis from non-small cell lung cancer(NSCLC) harboring EGFR mutation type by
intracranial PFS(iPFS),also PFS ,DCR and OS.The side effect is evaluated as well.